Oculus device receives FDA premarket approval

Key Points

Lynwood, WA-The FDA has granted premarket approval to a new pachymeter/auto-refractor/keratometer (PARK 1, Oculus).

The device was launched at the annual meeting of the American Academy of Ophthalmology in Atlanta.

The instrument is designed to photograph the eye and obtain a Scheimpflug image of the cornea to evaluate its thickness, according to the company. The implanted ophthalmic refractometer measures the refractive power of the eye.